Literature DB >> 4843266

Cancer of the prostate among men with benign prostatic hyperplasia.

P Greenwald, V Kirmss, A K Polan, V S Dick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4843266     DOI： 10.1093/jnci/53.2.335

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  16 in total

1.  Early (stage A) prostatic cancer. IV. Methodological criteria for histopathological diagnosis.

Authors:  S Battaglia; G Barbolini; A R Botticelli
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-06-29

2.  Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.

Authors:  Chu-Wen Fang; Cheng-Hsi Liao; Shih-Chi Wu; Chih-Hsin Muo
Journal:  World J Urol       Date:  2018-02-09       Impact factor: 4.226

Review 3.  Prostatic carcinoma: aspects of pathology, prognosis, and therapy.

Authors:  H Kastendieck
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

Review 4.  The link between benign prostatic hyperplasia and prostate cancer.

Authors:  David D Ørsted; Stig E Bojesen
Journal:  Nat Rev Urol       Date:  2012-11-20       Impact factor: 14.432

5.  Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.

Authors:  Jeannette M Schenk; Alan R Kristal; Kathryn B Arnold; Catherine M Tangen; Marian L Neuhouser; Daniel W Lin; Emily White; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2011-05-03       Impact factor: 4.897

6.  Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia.

Authors:  Joo Young Cha; Jungwon Wee; Jooyoung Jung; Yongwoo Jang; Byeongjun Lee; Gyu-Sang Hong; Beom Chul Chang; Yoon-La Choi; Young Kee Shin; Hye-Young Min; Ho-Young Lee; Tae-Young Na; Mi-Ock Lee; Uhtaek Oh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-07       Impact factor: 11.205

7.  Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations.

Authors:  K V Honn; A Aref; Y Q Chen; M L Cher; J D Crissman; J D Forman; X Gao; D Grignon; M Hussain; A T Porter; J E Pontes; I Powell; B Redman; W Sakr; R Severson; D G Tang; D P Wood
Journal:  Pathol Oncol Res       Date:  1996-03       Impact factor: 3.201

8.  Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate.

Authors:  G Dhom
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

9.  Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States).

Authors:  R A Hiatt; M A Armstrong; A L Klatsky; S Sidney
Journal:  Cancer Causes Control       Date:  1994-01       Impact factor: 2.506

Review 10.  Symptomatic diagnosis of prostate cancer in primary care: a structured review.

Authors:  William Hamilton; Deborah Sharp
Journal:  Br J Gen Pract       Date:  2004-08       Impact factor: 5.386
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.